FR2192811A1 - - Google Patents

Info

Publication number
FR2192811A1
FR2192811A1 FR7226158A FR7226158A FR2192811A1 FR 2192811 A1 FR2192811 A1 FR 2192811A1 FR 7226158 A FR7226158 A FR 7226158A FR 7226158 A FR7226158 A FR 7226158A FR 2192811 A1 FR2192811 A1 FR 2192811A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7226158A
Other versions
FR2192811B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CENTRE ETD IND PHARMA
Original Assignee
CENTRE ETD IND PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CENTRE ETD IND PHARMA filed Critical CENTRE ETD IND PHARMA
Priority to FR7226158A priority Critical patent/FR2192811B1/fr
Priority to AR249155A priority patent/AR205520A1/es
Priority to US376906A priority patent/US3906030A/en
Priority to CH983473A priority patent/CH575380A5/xx
Priority to BE133246A priority patent/BE802066A/fr
Priority to ZA734675A priority patent/ZA734675B/xx
Priority to GB3357573A priority patent/GB1383888A/en
Priority to CA176,902A priority patent/CA989838A/en
Priority to DE19732336670 priority patent/DE2336670A1/de
Priority to ES417042A priority patent/ES417042A1/es
Priority to JP8238073A priority patent/JPS5720938B2/ja
Publication of FR2192811A1 publication Critical patent/FR2192811A1/fr
Application granted granted Critical
Publication of FR2192811B1 publication Critical patent/FR2192811B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7226158A 1972-07-20 1972-07-20 Expired FR2192811B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR7226158A FR2192811B1 (fr) 1972-07-20 1972-07-20
AR249155A AR205520A1 (es) 1972-07-20 1973-01-01 Procedimiento de preparacion de esteres aminados derivados de esteres ortot moticos y sus sales de adicion con acidos y sus derivados de amonio cuaternarios
US376906A US3906030A (en) 1972-07-20 1973-07-05 New amino ether derivatives of orthothymotic esters
CH983473A CH575380A5 (fr) 1972-07-20 1973-07-05
BE133246A BE802066A (fr) 1972-07-20 1973-07-09 Ethers amines derives d'esters ortho-thymotiques
ZA734675A ZA734675B (en) 1972-07-20 1973-07-11 New amino derivatives of orthothymotic esters
GB3357573A GB1383888A (en) 1972-07-20 1973-07-13 Amino ether derivatives of orthothymatic esters
CA176,902A CA989838A (en) 1972-07-20 1973-07-19 Process for the preparation of new amino ether derivatives of orthothymotic esters
DE19732336670 DE2336670A1 (de) 1972-07-20 1973-07-19 Aminoaether von o-thymotinsaeureestern
ES417042A ES417042A1 (es) 1972-07-20 1973-07-19 Procedimiento de preparacion de nuevos eteres aminados de- rivados de esteres orto-timoticos.
JP8238073A JPS5720938B2 (fr) 1972-07-20 1973-07-20

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7226158A FR2192811B1 (fr) 1972-07-20 1972-07-20

Publications (2)

Publication Number Publication Date
FR2192811A1 true FR2192811A1 (fr) 1974-02-15
FR2192811B1 FR2192811B1 (fr) 1975-08-08

Family

ID=9102125

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7226158A Expired FR2192811B1 (fr) 1972-07-20 1972-07-20

Country Status (11)

Country Link
US (1) US3906030A (fr)
JP (1) JPS5720938B2 (fr)
AR (1) AR205520A1 (fr)
BE (1) BE802066A (fr)
CA (1) CA989838A (fr)
CH (1) CH575380A5 (fr)
DE (1) DE2336670A1 (fr)
ES (1) ES417042A1 (fr)
FR (1) FR2192811B1 (fr)
GB (1) GB1383888A (fr)
ZA (1) ZA734675B (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581643A1 (fr) * 1985-05-10 1986-11-14 Irceba Compositions pharmaceutiques utiles dans le domaine de l'urologie, contenant de l'acetoxy-1 methyl-2 ((piperidino)-2 ethoxy)-4 (methyl-1 ethyl)-5 benzene ou l'un de ses sels
FR2594122A1 (fr) * 1986-02-10 1987-08-14 Irceba ((pyrrolidinyl-1)-2 ethyoxy)-3 p cymene, les derives acetyl, acetoxy, hydroxy dudit produit et les medicaments contenant lesdits composes comme principe actif
FR2595357A1 (fr) * 1986-03-04 1987-09-11 Irceba (piperidino-3 propoxy)-5 p.cymene, les derives acetyl, acetoxy et hydroxy dudit produit, les sels de ces produits, un procede de preparation desdits produits et les medicaments contenant au moins un de ces produits comme principe actif
FR2614302A2 (fr) * 1986-02-10 1988-10-28 Irceba Derives du ((pyrrolidinul-1)-2 ethoxy)-5 p-cymene, procede pour leur preparation et medicaments en contenant.
EP0288647A1 (fr) * 1987-04-30 1988-11-02 INSTITUT DE RECHERCHES CHIMIQUES ET BIOLOGIQUES APPLIQUEES (I.R.C.E.B.A.) Société à responsabilité limitée dite: Dérivés du [(pyrrolidinyl-1)-2éthoxy]-5 p-cymène, le procédé de préparation desdits dérivés et les médicaments contenant lesdits dérivés

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54119428A (en) * 1978-02-24 1979-09-17 Hisamitsu Pharmaceut Co Inc Novel benzoic acid derivative
JP4799872B2 (ja) * 2004-03-31 2011-10-26 株式会社アクティバスファーマ 4級アンモニウム化合物、その製造方法及び脳血管障害治療剤
TWI356054B (en) * 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1241124A (fr) * 1957-02-21 1960-09-16 Bayer Ag Procédé pour la préparation d'alkyléthers d'esters de l'acide o-crésotique, substitués par des restes basiques

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1241124A (fr) * 1957-02-21 1960-09-16 Bayer Ag Procédé pour la préparation d'alkyléthers d'esters de l'acide o-crésotique, substitués par des restes basiques

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ARZNEIMITTEL-FORSCHUNG", VOL 10, PAGES 170-174 1960 ) *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581643A1 (fr) * 1985-05-10 1986-11-14 Irceba Compositions pharmaceutiques utiles dans le domaine de l'urologie, contenant de l'acetoxy-1 methyl-2 ((piperidino)-2 ethoxy)-4 (methyl-1 ethyl)-5 benzene ou l'un de ses sels
FR2594122A1 (fr) * 1986-02-10 1987-08-14 Irceba ((pyrrolidinyl-1)-2 ethyoxy)-3 p cymene, les derives acetyl, acetoxy, hydroxy dudit produit et les medicaments contenant lesdits composes comme principe actif
FR2614302A2 (fr) * 1986-02-10 1988-10-28 Irceba Derives du ((pyrrolidinul-1)-2 ethoxy)-5 p-cymene, procede pour leur preparation et medicaments en contenant.
FR2595357A1 (fr) * 1986-03-04 1987-09-11 Irceba (piperidino-3 propoxy)-5 p.cymene, les derives acetyl, acetoxy et hydroxy dudit produit, les sels de ces produits, un procede de preparation desdits produits et les medicaments contenant au moins un de ces produits comme principe actif
EP0237411A1 (fr) * 1986-03-04 1987-09-16 INSTITUT DE RECHERCHES CHIMIQUES ET BIOLOGIQUES APPLIQUEES (I.R.C.E.B.A.) Société à responsabilité limitée dite: (Pipéridino-3)propoxy - 5p.cymène, les dérivés acétyl, acétoxy et hydroxy dudit produit, les sels de ces produits un procédé de préparation desdits produits et les médicaments contenant au moins un de ces produits comme principe actif
EP0288647A1 (fr) * 1987-04-30 1988-11-02 INSTITUT DE RECHERCHES CHIMIQUES ET BIOLOGIQUES APPLIQUEES (I.R.C.E.B.A.) Société à responsabilité limitée dite: Dérivés du [(pyrrolidinyl-1)-2éthoxy]-5 p-cymène, le procédé de préparation desdits dérivés et les médicaments contenant lesdits dérivés

Also Published As

Publication number Publication date
ES417042A1 (es) 1976-03-01
DE2336670A1 (de) 1974-01-31
JPS4943936A (fr) 1974-04-25
BE802066A (fr) 1973-11-05
JPS5720938B2 (fr) 1982-05-04
ZA734675B (en) 1974-06-26
CA989838A (en) 1976-05-25
FR2192811B1 (fr) 1975-08-08
GB1383888A (en) 1974-02-12
CH575380A5 (fr) 1976-05-14
AR205520A1 (es) 1976-05-14
US3906030A (en) 1975-09-16

Similar Documents

Publication Publication Date Title
JPS4964999A (fr)
FR2191215B3 (fr)
FR2192811B1 (fr)
JPS4990914A (fr)
JPS48103096A (fr)
FR2205656B1 (fr)
FR2208017B3 (fr)
JPS5518898B2 (fr)
JPS4960460A (fr)
JPS5153425Y2 (fr)
SU431951A1 (fr)
JPS496610U (fr)
CH574772A5 (fr)
CH571434A5 (fr)
CH576683A5 (fr)
CH576520A5 (fr)
CH576435A5 (fr)
CH576369A5 (fr)
CH576317A5 (fr)
CH576294A5 (fr)
CH576158A5 (fr)
CH567731A5 (fr)
CH574728A5 (fr)
CH574551A5 (fr)
CH573034A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse